| Pharmaceutical active ingredients: |
| EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Systen Sequi: |
| Patch; Topical; Estradiol 0.05 mg / Patch; Topical; Estradiol 0.05 mg; Norethindrone Acetate 0.17 mg / 24 h |
| Systen Sequi medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA53 - Estradiol, combinationsG03FA01 - Norethisterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| JanssenLohmann & Rauscher Laboratoires |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Natifa Pro | Estradiol; Norethindrone Acetate | Libbs Farmaceutica |
| Pausogest | Estradiol; Norethindrone Acetate | Gedeon Richter |
| Perikliman | Estradiol; Norethindrone Acetate | F. Joh. Kwizda |
| Suprema | Estradiol; Norethindrone Acetate | Biolab Sanus Farmaceutica |
| Systen Conti | Estradiol; Norethindrone Acetate | Janssen; Lohmann & Rauscher Laboratoires |
| Tesor-C | Estradiol; Norethindrone Acetate | Segix Italia |
| Trial Combi | Estradiol; Norethindrone Acetate | Beta Laboratorios |
| Trial Gest | Estradiol; Norethindrone Acetate | Beta Laboratorios |
| Trial Pack | Estradiol; Norethindrone Acetate | Beta Laboratorios |
| Trisekvens | Estradiol; Norethindrone Acetate | Novo Nordisk |